Clinical Chemistry Analyzer Market Definition
Clinical chemistry analysers are the devices used to determine the concentration of certain metabolites, electrolytes, proteins, and drugs in samples of plasma, urine, serum, cerebrospinal fluid, and/or other body fluids. Significant advancement in healthcare industry and increase in population across globe have boosted the demand for clinical chemistry analyser market. North America held the largest market share of the clinical chemistry analyser due to various government supportive policies & guidelines and high investments in research and testing.
The market study is broken down by Type (Low-Volume Chemistry Analyser, Automated Chemistry Analyser, Fully Automated Bench-top Analyser, Random Access Chemistry Analyser and Other), by Application (Academic Research Institutes, Diagnostics Laboratories, Hospitals and Other) and major geographies with country level splits.
The Players having a strong hold in the market are Roche Diagnostics, Beckman Coulter, Abbott Diagnostics, and Siemens AG. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Clinical Chemistry Analyzer market throughout the predicted period.
Beckman Coulter (United States), Abbott Diagnostics (United States), Siemens AG (Germany), Roche Diagnostics (Switzerland), Ortho-Clinical Diagnostics (United States), Thermo Fisher Scientific (United States), Randox Laboratories Ltd. (United Kingdom), ElitechGroup (France), Mindray (China) and Horiba (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Danaher Corporation (United States), DASA S.A (Brazil), Johnson & Johnson (United States), Labcompare (United States) and Hitachi (Japan).
AdvanceMarketAnalytics has segmented the market of Global Clinical Chemistry Analyzer market by Type, Application and Region.
On the basis of geography, the market of Clinical Chemistry Analyzer has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Measurement Technology, the sub-segment i.e. Photometric and Colorimetric Testing will boost the Clinical Chemistry Analyzer market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Size, the sub-segment i.e. Small (400-800 Test/H) will boost the Clinical Chemistry Analyzer market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
On January 16, 2019, Abbott, a leading healthcare company, has announced that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held medical device company developing a less-invasive heart valve replacement technology for people with mitral valve disease.
On May 2, 2019, Beckman Coulter, a global leader in clinical diagnostics, announced that the latest addition to its market-leading automation portfolio, the DxA 5000 total laboratory automation solution has achieved European CE Mark and China Food and Drug Administration approval. The DxA 5000 supports laboratories in delivering highly consistent turnaround time to their physicians.
The Medical Device Amendments (MDA) of 1976 was passed to amend the FFDCA to “provide for the safety and effectiveness of medical devices”. The MDA includes an amendment to the FFDCA and the Federal Trade Commission Act to specifically define a “device” as any “instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease. Thus, in vitro reagents, as well as in vitro diagnostic products, when used for the diagnosis of disease are considered as medical devices under current federal regulations.
- Modern Clinical Laboratory Testing and Automation
- Rising number of chronic diseases such as diabetes & cancers owing to unhealthy lifestyle of people is the key driving factor for the market. Moreover, the growing geriatric population worldwide has also fuelling the demand of the market.
- High Expenditure on Healthcare Equipment’s due To Laboratory Automation
- Advancements in Computer Technology and Real-Time Automation are Creating Lucrative Opportunities for the Market.
- High Cost of the Product
- Lack of Skilled and Trained Professionals
- Risk of Outcome Ambiguity
- Intense Competition in the Industry
Key Target Audience
Clinical Laboratories and testing Centres, Hospitals and Clinics, Research Institutes and Organization and Industry Bodies and Association
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase